|
|||||
|
|

Insurance data analytics provider Verisk Analytics (NASDAQ:VRSK) met Wall Street’s revenue expectations in Q2 CY2025, with sales up 7.8% year on year to $772.6 million. The company’s full-year revenue guidance of $3.11 billion at the midpoint came in 1% above analysts’ estimates. Its non-GAAP profit of $1.88 per share was 6.1% above analysts’ consensus estimates.
Is now the time to buy VRSK? Find out in our full research report (it’s free).
Verisk's second quarter results met Wall Street’s revenue expectations, but the market responded negatively, with shares trading down sharply post-release. Management attributed operating momentum to broad-based subscription growth, disciplined cost management, and healthy margin expansion across its insurance analytics businesses. CEO Lee Shavel highlighted the company’s continued transformation into an integrated technology network, with new AI-powered solutions and expanded data offerings playing a central role. However, management acknowledged persistent headwinds in the auto and sustainability segments, as well as tougher year-over-year comparisons due to strong prior performance. CFO Elizabeth Mann noted that some competitive pressures and government contract reductions also impacted transactional revenue growth.
Looking forward, Verisk’s updated guidance is influenced by the anticipated contributions from recent acquisitions and ongoing investments in product innovation, particularly in AI-driven solutions. Management emphasized the integration of AccuLynx and SuranceBay as key to expanding recurring revenue and enhancing the company’s ecosystem. CFO Elizabeth Mann cautioned that margin expansion may be tempered by onetime integration costs and increased interest expense related to acquisition financing. Shavel pointed to continued focus on value creation and connectivity across the insurance workflow, stating, “We are energized about working together to enhance the network effect of these businesses and maximize value for the property claims and life insurance ecosystems.”
Management linked the quarter’s solid growth and margins to recurring subscription revenues, new AI product launches, and recent acquisitions that reinforce the company’s insurance focus.
Management expects future performance to be shaped by M&A integration, technology investments, and evolving industry demand—balanced against margin pressures from one-time costs and competitive dynamics.
In the coming quarters, the StockStory team will monitor (1) the pace and success of AccuLynx and SuranceBay integrations, (2) adoption rates and client feedback on new AI-driven product features, and (3) stabilization in transactional revenue streams—especially in the auto and sustainability segments. Execution on these fronts, as well as the ability to manage acquisition-related costs and leverage, will be key to assessing Verisk’s progress toward its strategic objectives.
Verisk currently trades at $267.42, down from $294.11 just before the earnings. At this price, is it a buy or sell? Find out in our full research report (it’s free).
Trump’s April 2025 tariff bombshell triggered a massive market selloff, but stocks have since staged an impressive recovery, leaving those who panic sold on the sidelines.
Take advantage of the rebound by checking out our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
| Nov-05 | |
| Nov-05 | |
| Nov-03 | |
| Nov-03 | |
| Oct-30 | |
| Oct-30 | |
| Oct-30 | |
| Oct-29 | |
| Oct-29 | |
| Oct-29 | |
| Oct-29 | |
| Oct-29 | |
| Oct-29 | |
| Oct-29 | |
| Oct-29 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite